Skip to main content
Erschienen in: Inflammation 6/2017

26.07.2017 | ORIGINAL ARTICLE

Schisandrin B Ameliorates Myocardial Ischemia/Reperfusion Injury Through Attenuation of Endoplasmic Reticulum Stress-Induced Apoptosis

verfasst von: Wei Zhang, Zhiqing Sun, Fanhua Meng

Erschienen in: Inflammation | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Schisandrin B (Sch B), an active composition isolated from the fruit of Schisandra chinensis, has been proved to possess antiinflammatory, antioxidant and anti-endoplasmic reticulum (ER) stress effects in many rodent tissues. However, the exact mechanism of cardioprotective effect of Sch B still needs more study. Here, we detected the effects of Sch B on myocardial ischemia/reperfusion (I/R) injury rats. I/R injury model in this study was established by left anterior descending coronary artery ligation for 40 min followed by 1 h of reperfusion. Male healthy rats were randomly divided into five groups: the sham, I/R, Sch B (20 mg/kg) + I/R, and Sch B (40 mg/kg) + I/R, Sch B (80 mg/kg) + I/R, with 10 rats in each group. We showed that Sch B treatment significantly protected against myocardial I/R injury, as demonstrated by the decrease in the percentage of infarct formation assessed by 2,3,5-triphenyl tetrazolium chloride (TTC) staining in representative heart tissue slices, comparing with the I/R control group. The levels of creatine kinase (CK), lactate dehydrogenase (LDH), malondialdehyde (MDA), and total superoxide dismutase (T-SOD) were tested. The ER stress-related proteins such as C/EBP homologous protein (CHOP), activating transcription factor 6 (ATF6), and (PKR)-like ER kinase (PERK) were further measured by western blot, and their messenger RNA levels were measured by real-time PCR. The apoptosis of heart tissue cells was also tested through the expressions of caspase-9, caspase-3, Bcl-2, and Bax proteins. Collectively, these results revealed that Sch B exerts protection role on myocardial I/R injury through decreasing oxidative reaction, suppressing ATF6 and PERK pathway, and attenuating ER stress-induced apoptosis.
Literatur
1.
Zurück zum Zitat Forouzanfar, M.H., A.E. Moran, A.D. Flaxman, G. Roth, G.A. Mensah, M. Ezzati, M. Naghavi, and C.J. Murray. 2012. Assessing the global burden of ischemic heart disease, part 2: analytic methods and estimates of the global epidemiology of ischemic heart disease in 2010. Global Heart 7: 331–342.CrossRefPubMedPubMedCentral Forouzanfar, M.H., A.E. Moran, A.D. Flaxman, G. Roth, G.A. Mensah, M. Ezzati, M. Naghavi, and C.J. Murray. 2012. Assessing the global burden of ischemic heart disease, part 2: analytic methods and estimates of the global epidemiology of ischemic heart disease in 2010. Global Heart 7: 331–342.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Ibanez, B., G. Heusch, M. Ovize, and F. Van, de Werf. 2015. Evolving therapies for myocardial ischemia/reperfusion injury. Journal of the American College of Cardiology 65: 1454–1471.CrossRefPubMed Ibanez, B., G. Heusch, M. Ovize, and F. Van, de Werf. 2015. Evolving therapies for myocardial ischemia/reperfusion injury. Journal of the American College of Cardiology 65: 1454–1471.CrossRefPubMed
3.
Zurück zum Zitat Chi, H.J., Chen, M.L., Yang, X.C., Lin, X.M., Sun, H., Zhao, W.S., Qi, D., Cai, J., and Dong, J.L. 2016. Progress in therapies for myocardial ischemia reperfusion injury. Current drug targets 17. Chi, H.J., Chen, M.L., Yang, X.C., Lin, X.M., Sun, H., Zhao, W.S., Qi, D., Cai, J., and Dong, J.L. 2016. Progress in therapies for myocardial ischemia reperfusion injury. Current drug targets 17.
4.
Zurück zum Zitat Yang, Q., G.W. He, M.J. Underwood, and C.M. Yu. 2016. Cellular and molecular mechanisms of endothelial ischemia/reperfusion injury: perspectives and implications for postischemic myocardial protection. American Journal of Translational Research 8: 765–777.PubMedPubMedCentral Yang, Q., G.W. He, M.J. Underwood, and C.M. Yu. 2016. Cellular and molecular mechanisms of endothelial ischemia/reperfusion injury: perspectives and implications for postischemic myocardial protection. American Journal of Translational Research 8: 765–777.PubMedPubMedCentral
6.
Zurück zum Zitat Moens, A.L., M.J. Claeys, J.P. Timmermans, and C.J. Vrints. 2005. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. International Journal of Cardiology 100: 179–190.CrossRefPubMed Moens, A.L., M.J. Claeys, J.P. Timmermans, and C.J. Vrints. 2005. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. International Journal of Cardiology 100: 179–190.CrossRefPubMed
7.
Zurück zum Zitat Lu, S.F., Y. Huang, N. Wang, W.X. Shen, S.P. Fu, Q. Li, M.L. Yu, W.X. Liu, X. Chen, X.Y. Jing, and B.M. Zhu. 2016. Cardioprotective effect of electroacupuncture pretreatment on myocardial ischemia/reperfusion injury via antiapoptotic signaling. Evidence-based complementary and alternative medicine : eCAM 2016: 4609784. Lu, S.F., Y. Huang, N. Wang, W.X. Shen, S.P. Fu, Q. Li, M.L. Yu, W.X. Liu, X. Chen, X.Y. Jing, and B.M. Zhu. 2016. Cardioprotective effect of electroacupuncture pretreatment on myocardial ischemia/reperfusion injury via antiapoptotic signaling. Evidence-based complementary and alternative medicine : eCAM 2016: 4609784.
8.
Zurück zum Zitat Xu, C., B. Bailly-Maitre, and J.C. Reed. 2005. Endoplasmic reticulum stress: cell life and death decisions. The Journal of Clinical Investigation 115: 2656–2664.CrossRefPubMedPubMedCentral Xu, C., B. Bailly-Maitre, and J.C. Reed. 2005. Endoplasmic reticulum stress: cell life and death decisions. The Journal of Clinical Investigation 115: 2656–2664.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Liu, M.Q., Z. Chen, and L.X. Chen. 2016. Endoplasmic reticulum stress: a novel mechanism and therapeutic target for cardiovascular diseases. Acta Pharmacologica Sinica 37: 425–443.CrossRefPubMedPubMedCentral Liu, M.Q., Z. Chen, and L.X. Chen. 2016. Endoplasmic reticulum stress: a novel mechanism and therapeutic target for cardiovascular diseases. Acta Pharmacologica Sinica 37: 425–443.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Ron, D., and P. Walter. 2007. Signal integration in the endoplasmic reticulum unfolded protein response. Nature Reviews Molecular Cell Biology 8: 519–529.CrossRefPubMed Ron, D., and P. Walter. 2007. Signal integration in the endoplasmic reticulum unfolded protein response. Nature Reviews Molecular Cell Biology 8: 519–529.CrossRefPubMed
11.
Zurück zum Zitat Thuerauf, D.J., M. Marcinko, N. Gude, M. Rubio, M.A. Sussman, and C.C. Glembotski. 2006. Activation of the unfolded protein response in infarcted mouse heart and hypoxic cultured cardiac myocytes. Circulation Research 99: 275–282.CrossRefPubMed Thuerauf, D.J., M. Marcinko, N. Gude, M. Rubio, M.A. Sussman, and C.C. Glembotski. 2006. Activation of the unfolded protein response in infarcted mouse heart and hypoxic cultured cardiac myocytes. Circulation Research 99: 275–282.CrossRefPubMed
12.
Zurück zum Zitat Walter, P., and D. Ron. 2011. The unfolded protein response: from stress pathway to homeostatic regulation. Science 334: 1081–1086.CrossRefPubMed Walter, P., and D. Ron. 2011. The unfolded protein response: from stress pathway to homeostatic regulation. Science 334: 1081–1086.CrossRefPubMed
13.
14.
Zurück zum Zitat Shen, X., K. Zhang, and R.J. Kaufman. 2004. The unfolded protein response—a stress signaling pathway of the endoplasmic reticulum. Journal of Chemical Neuroanatomy 28: 79–92.CrossRefPubMed Shen, X., K. Zhang, and R.J. Kaufman. 2004. The unfolded protein response—a stress signaling pathway of the endoplasmic reticulum. Journal of Chemical Neuroanatomy 28: 79–92.CrossRefPubMed
15.
Zurück zum Zitat Panossian, A., and G. Wikman. 2008. Pharmacology of Schisandra Chinensis bail.: an overview of Russian research and uses in medicine. Journal of Ethnopharmacology 118: 183–212.CrossRefPubMed Panossian, A., and G. Wikman. 2008. Pharmacology of Schisandra Chinensis bail.: an overview of Russian research and uses in medicine. Journal of Ethnopharmacology 118: 183–212.CrossRefPubMed
16.
Zurück zum Zitat Ip, S.P., M.K.T. Poon, S.S. Wu, C.T. Che, K.H. Ng, Y.C. Kong, and K.M. Ko. 1995. Effect of Schisandrin-B on hepatic glutathione antioxidant system in mice—protection against carbon-tetrachloride toxicity. Planta Medica 61: 398–401.CrossRefPubMed Ip, S.P., M.K.T. Poon, S.S. Wu, C.T. Che, K.H. Ng, Y.C. Kong, and K.M. Ko. 1995. Effect of Schisandrin-B on hepatic glutathione antioxidant system in mice—protection against carbon-tetrachloride toxicity. Planta Medica 61: 398–401.CrossRefPubMed
17.
Zurück zum Zitat Checker, R., R.S. Patwardhan, D. Sharma, J. Menon, M. Thoh, H.N. Bhilwade, T. Konishi, and S.K. Sandur. 2012. Schisandrin B exhibits anti-inflammatory activity through modulation of the redox-sensitive transcription factors Nrf2 and NF-kappaB. Free Radical Biology & Medicine 53: 1421–1430.CrossRef Checker, R., R.S. Patwardhan, D. Sharma, J. Menon, M. Thoh, H.N. Bhilwade, T. Konishi, and S.K. Sandur. 2012. Schisandrin B exhibits anti-inflammatory activity through modulation of the redox-sensitive transcription factors Nrf2 and NF-kappaB. Free Radical Biology & Medicine 53: 1421–1430.CrossRef
18.
Zurück zum Zitat Xu, Y., Liu, Z., Sun, J., Pan, Q.R., Sun, F.F., Yan, Z.Y., and Hu, X. 2011. Schisandrin B prevents doxorubicin-induced chronic cardiotoxicity and enhances its anticancer activity in vivo. Plos One 6. Xu, Y., Liu, Z., Sun, J., Pan, Q.R., Sun, F.F., Yan, Z.Y., and Hu, X. 2011. Schisandrin B prevents doxorubicin-induced chronic cardiotoxicity and enhances its anticancer activity in vivo. Plos One 6.
19.
Zurück zum Zitat Ko, K.M. 2004. Schisandrin B and other dibenzocyclooctadiene lignans. In: Herbal Medicines: Molecular Basis in Health & Diseases Management. Marcel Dekker New York Basel Hong Kong. 289–314. Ko, K.M. 2004. Schisandrin B and other dibenzocyclooctadiene lignans. In: Herbal Medicines: Molecular Basis in Health & Diseases Management. Marcel Dekker New York Basel Hong Kong. 289–314.
20.
Zurück zum Zitat Yu, D., M. Li, Y. Tian, J. Liu, and J. Shang. 2015. Luteolin inhibits ROS-activated MAPK pathway in myocardial ischemia/reperfusion injury. Life Sciences 122: 15–25.CrossRefPubMed Yu, D., M. Li, Y. Tian, J. Liu, and J. Shang. 2015. Luteolin inhibits ROS-activated MAPK pathway in myocardial ischemia/reperfusion injury. Life Sciences 122: 15–25.CrossRefPubMed
21.
Zurück zum Zitat Duehrkop, C., and R. Rieben. 2014. Ischemia/reperfusion injury: effect of simultaneous inhibition of plasma cascade systems versus specific complement inhibition. Biochemical Pharmacology 88: 12–22.CrossRefPubMed Duehrkop, C., and R. Rieben. 2014. Ischemia/reperfusion injury: effect of simultaneous inhibition of plasma cascade systems versus specific complement inhibition. Biochemical Pharmacology 88: 12–22.CrossRefPubMed
22.
Zurück zum Zitat Yim, T.K., and K.M. Ko. 1999. Schisandrin B protects against myocardial ischemia-reperfusion injury by enhancing myocardial glutathione antioxidant status. Molecular and Cellular Biochemistry 196: 151–156.CrossRefPubMed Yim, T.K., and K.M. Ko. 1999. Schisandrin B protects against myocardial ischemia-reperfusion injury by enhancing myocardial glutathione antioxidant status. Molecular and Cellular Biochemistry 196: 151–156.CrossRefPubMed
23.
Zurück zum Zitat Chiu, P.Y., and K.M. Ko. 2003. Time-dependent enhancement in mitochondrial glutathione status and ATP generation capacity by schisandrin B treatment decreases the susceptibility of rat hearts to ischemia-reperfusion injury. BioFactors 19: 43–51.CrossRefPubMed Chiu, P.Y., and K.M. Ko. 2003. Time-dependent enhancement in mitochondrial glutathione status and ATP generation capacity by schisandrin B treatment decreases the susceptibility of rat hearts to ischemia-reperfusion injury. BioFactors 19: 43–51.CrossRefPubMed
24.
Zurück zum Zitat Ko, K.M., and H.Y. Yiu. 2001. Schisandrin B modulates the ischemia-reperfusion induced changes in non-enzymatic antioxidant levels in isolated-perfused rat hearts. Molecular and Cellular Biochemistry 220: 141–147.CrossRefPubMed Ko, K.M., and H.Y. Yiu. 2001. Schisandrin B modulates the ischemia-reperfusion induced changes in non-enzymatic antioxidant levels in isolated-perfused rat hearts. Molecular and Cellular Biochemistry 220: 141–147.CrossRefPubMed
25.
Zurück zum Zitat Chiu, P.Y., H.Y. Leung, A.H. Siu, M.K. Poon, and K.M. Ko. 2007. Schisandrin B decreases the sensitivity of mitochondria to calcium ion-induced permeability transition and protects against ischemia-reperfusion injury in rat hearts. Acta Pharmacologica Sinica 28: 1559–1565.CrossRefPubMed Chiu, P.Y., H.Y. Leung, A.H. Siu, M.K. Poon, and K.M. Ko. 2007. Schisandrin B decreases the sensitivity of mitochondria to calcium ion-induced permeability transition and protects against ischemia-reperfusion injury in rat hearts. Acta Pharmacologica Sinica 28: 1559–1565.CrossRefPubMed
26.
Zurück zum Zitat Chiu, P.Y., and K.M. Ko. 2004. Schisandrin B protects myocardial ischemia-reperfusion injury partly by inducing Hsp25 and Hsp70 expression in rats. Molecular and Cellular Biochemistry 266: 139–144.CrossRefPubMed Chiu, P.Y., and K.M. Ko. 2004. Schisandrin B protects myocardial ischemia-reperfusion injury partly by inducing Hsp25 and Hsp70 expression in rats. Molecular and Cellular Biochemistry 266: 139–144.CrossRefPubMed
27.
Zurück zum Zitat Qi, X., A. Vallentin, E. Churchill, and D. Mochly-Rosen. 2007. deltaPKC participates in the endoplasmic reticulum stress-induced response in cultured cardiac myocytes and ischemic heart. Journal of Molecular and Cellular Cardiology 43: 420–428.CrossRefPubMedPubMedCentral Qi, X., A. Vallentin, E. Churchill, and D. Mochly-Rosen. 2007. deltaPKC participates in the endoplasmic reticulum stress-induced response in cultured cardiac myocytes and ischemic heart. Journal of Molecular and Cellular Cardiology 43: 420–428.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Jian, L., Y. Lu, S. Lu, and C. Lu. 2016. Chemical chaperone 4-Phenylbutyric acid reduces cardiac ischemia/reperfusion injury by alleviating endoplasmic reticulum stress and oxidative stress. Medical Science Monitor 22: 5218–5227.CrossRefPubMedPubMedCentral Jian, L., Y. Lu, S. Lu, and C. Lu. 2016. Chemical chaperone 4-Phenylbutyric acid reduces cardiac ischemia/reperfusion injury by alleviating endoplasmic reticulum stress and oxidative stress. Medical Science Monitor 22: 5218–5227.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Chen, C.M., C.T. Wu, C.K. Chiang, B.W. Liao, and S.H. Liu. 2012. C/EBP homologous protein (CHOP) deficiency aggravates hippocampal cell apoptosis and impairs memory performance. PloS One 7: e40801.CrossRefPubMedPubMedCentral Chen, C.M., C.T. Wu, C.K. Chiang, B.W. Liao, and S.H. Liu. 2012. C/EBP homologous protein (CHOP) deficiency aggravates hippocampal cell apoptosis and impairs memory performance. PloS One 7: e40801.CrossRefPubMedPubMedCentral
Metadaten
Titel
Schisandrin B Ameliorates Myocardial Ischemia/Reperfusion Injury Through Attenuation of Endoplasmic Reticulum Stress-Induced Apoptosis
verfasst von
Wei Zhang
Zhiqing Sun
Fanhua Meng
Publikationsdatum
26.07.2017
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 6/2017
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-017-0631-4

Weitere Artikel der Ausgabe 6/2017

Inflammation 6/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.